What Researchers Did
Researchers investigated how hyperbaric oxygen therapy, as part of a comprehensive treatment, influenced the immune response in patients diagnosed with peritonitis.
What They Found
Patients with peritonitis who received hyperbaric oxygen therapy showed a reduction in delayed hypersensitivity to common bacteria like staphylococcus, Proteus, blue pus bacillus, and E. coli. At the same time, their bodies produced more antibodies against these bacteria. However, levels of staphylococcal alpha-antitoxin in their blood remained lower than in healthy individuals, even with HBO.
What This Means for Canadian Patients
For Canadian patients suffering from peritonitis, this research suggests that adding hyperbaric oxygen therapy to their treatment could potentially help their immune system fight off bacterial infections more effectively. This might lead to better management of severe abdominal infections by modulating the body's immune response.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract does not provide details on the study's design, sample size, specific hyperbaric oxygen therapy protocols used, or long-term outcomes.